THE DEAL, AT A GLANCE
From the announcementFoundation Medicine
01Who is involvedBacked by Roche (parent company)From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedFoundation Medicine raised $150M Growth RoundFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersFoundation Medicine is financing broader comprehensive genomic profiling for cancer treatment through a Growth Round led by Roche.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Foundation Medicine · Financing Record
Explore source-linked visual explanations for Foundation Medicine. Unsupported claims are withheld while source review continues.
Record 459 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →